<DOC>
	<DOCNO>NCT01821404</DOCNO>
	<brief_summary>This single-center , randomize , double-blind trial ass impact short-term atorvastatin administration proliferation activity , apoptotic rate histological inflammation prostate tissue .</brief_summary>
	<brief_title>Atorvastatin Before Prostatectomy Prostate Cancer</brief_title>
	<detailed_description>In trial 160 men diagnose prostate cancer , whose first-line treatment radical prostatectomy ( surgical removal prostate ) , randomize receive either 80 mg atorvastatin placebo daily 2-5 week operation . Blood cholesterol serum PSA measure start study drug use operation . After operation change PSA histological inflammation , apoptotic rate Ki-67 staining intensity compare atorvastatin-treated placebo-treated men . The correlation change serum cholesterol prostate specific antigen ( PSA ) tissue characteristic evaluate . After recruit 60 men perform interim analysis primary end-points without break blind treatment allocation . If observe statistically significant difference primary end-points , trial stop early result publish . Additionally , atorvastatin concentration blood prostate tissue measure mass spectrometry determine penetrance atorvastatin prostate . DNA- RNA-samples obtain prostate tissue blood . These use study gene expression statin- cholesterol-modifying enzyme affect response observe prostate tissue . As secondary end-point measure recovery erectile function operation compare two study arm . Erectile function measure use IIEF-5 questionnaire operation 3 , 6 , 9 12 month prostatectomy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Prostate cancer proven histologically prostate biopsy Radical prostatectomy select firstline treatment Willingness participate sign inform consent Previous oncological treatment malignancy Previous usage statin , finasteride dutasteride within year prior prostate cancer diagnosis Clinically significant liver kidney insufficiency ( plasma alanine aminotransferase level twice recommend upper limit serum creatinine level 170 Âµmol/l ) Previous adverse effect cholesterollowering treatment Ongoing use drug interaction statin ( St John 's Wort , HIV protease inhibitor , ciclosporin , macrolide antibiotic , fusidic acid , phenytoin , carbamazepine , dronedarone oral antifungal medication )</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Apoptosis</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Pre-surgical trial</keyword>
	<keyword>Proliferation</keyword>
	<keyword>Prostate cancer</keyword>
</DOC>